
1. j med virol. 1994 jul;43(3):222-7.

iga directed early antigen epstein-barr virus specific marker
for diagnosis nasopharyngeal carcinoma.

sigel g(1), schillinger m, henninger k, bauer g.

author information: 
(1)abteilung virologie, universitÃ¤t freiburg, germany.

the aim study evaluate significance specificity iga
directed epstein-barr virus (ebv)-specific early antigens (ea) the
unequivocal diagnosis nasopharyngeal carcinoma (npc). therefore, sera from
patients diseases npc, selected basis elevated antibody
titres ebv antigens, compared sera npc patients regard 
to presence iga directed ebv viral capsid antigen (vca-iga) and
iga directed ea (ea-iga). four hundred forty-seven 7,508 non-npc
sera tested showed high titres (> 512) igg directed epstein barr viral
capsid antigen (vca-igg) positive vca-iga (> = 32). two hundred
twenty-seven sera compared 51 vca-iga-positive sera npc
patients regarding titre ea-iga. 60.7% vca-iga-positive npc sera showed
positive ea-iga, however 33% vca-iga-positive non-npc patients also exhibited 
ea-iga. result demonstrates ea-iga specific npc not
allow unequivocal serological diagnosis npc individual cases. seems
therefore questionable use screening programs npc low-risk areas.
the data contradict usefulness marker monitoring of
patients treated npc screening programmes high-risk areas.

doi: 10.1002/jmv.1890430305 
pmid: 7931181  [indexed medline]

